| scholarly article | Q13442814 |
| P2093 | author name string | Bruce D Levy | |
| Thomas Michel | |||
| Toru Sugiyama | |||
| P2860 | cites work | Regulation of endothelium-derived nitric oxide production by the protein kinase Akt | Q22010149 |
| Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 | ||
| GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation | Q24304352 | ||
| Tetrahydrobiopterin biosynthesis, regeneration and functions | Q24531994 | ||
| Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center | Q27766420 | ||
| Pulmonary phosphatidic acid phosphatase and lipid phosphate phosphohydrolase | Q28216832 | ||
| Regulation of endothelial nitric oxide synthase: location, location, location | Q28217344 | ||
| The regulation and pharmacology of endothelial nitric oxide synthase | Q28290711 | ||
| The Akt kinase signals directly to endothelial nitric oxide synthase | Q28609847 | ||
| The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study | Q28609860 | ||
| Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension | Q30080036 | ||
| Intracellular formation of ”undisruptable” dimers of inducible nitric oxide synthase | Q31024396 | ||
| Mammalian nitric oxide synthases | Q33631306 | ||
| Endothelium-derived nitric oxide and vascular physiology and pathology | Q33708030 | ||
| Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer | Q33722120 | ||
| Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src | Q33871655 | ||
| Oxygen reduction by nitric-oxide synthases | Q34201782 | ||
| Nitric oxide insufficiency, platelet activation, and arterial thrombosis | Q34234301 | ||
| Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? | Q34341995 | ||
| Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease | Q34375943 | ||
| Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects. | Q34633011 | ||
| Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase | Q35026148 | ||
| Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis | Q35058386 | ||
| Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors | Q36253833 | ||
| Delivery of exogenous tetrahydrobiopterin (BH4) to cells of target organs: role of salvage pathway and uptake of its precursor in effective elevation of tissue BH4. | Q36300275 | ||
| Phosphorylation and subcellular translocation of endothelial nitric oxide synthase | Q36402798 | ||
| Tetrahydrobiopterin and cardiovascular disease | Q36583184 | ||
| Diminished lipoxin biosynthesis in severe asthma | Q37282577 | ||
| Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. | Q37294875 | ||
| Nitric oxide synthases: which, where, how, and why? | Q37374087 | ||
| Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression | Q39916287 | ||
| Nitric oxide and its role in the cardiovascular system | Q40418256 | ||
| Characterization of a cis-acting regulatory element in the protein-coding region of human dihydrofolate reductase mRNA. | Q40609122 | ||
| Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase | Q41093585 | ||
| Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency | Q42090666 | ||
| Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation | Q43599368 | ||
| Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. | Q44018080 | ||
| Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase | Q44110016 | ||
| Folic acid reverses endothelial dysfunction induced by inhibition of tetrahydrobiopterin biosynthesis | Q46874738 | ||
| Evaluation of assays for the measurement of bovine neutrophil reactive oxygen species. | Q50716938 | ||
| Epinephrine regulation of the endothelial nitric-oxide synthase: roles of RAC1 and beta3-adrenergic receptors in endothelial NO signaling. | Q53527970 | ||
| Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric-oxide synthase. | Q54039650 | ||
| Low-Temperature Optical Absorption Spectra Suggest a Redox Role for Tetrahydrobiopterin in Both Steps of Nitric Oxide Synthase Catalysis† | Q61906284 | ||
| Analysis of reduced forms of biopterin in biological tissues and fluids | Q71136634 | ||
| 2,4-Diamino-6-hydroxypyrimidine, an inhibitor of tetrahydrobiopterin synthesis, downregulates the expression of iNOS protein and mRNA in primary murine macrophages | Q71690294 | ||
| Tetrahydrobiopterin and endothelial nitric oxide synthase activity | Q73119905 | ||
| Acceleration of oxidative stress-induced endothelial cell death by nitric oxide synthase dysfunction accompanied with decrease in tetrahydrobiopterin content | Q73575143 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| sapropterin | Q419808 | ||
| P304 | page(s) | 12691-12700 | |
| P577 | publication date | 2009-03-12 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells | |
| P478 | volume | 284 |
| Q41776091 | Active NF-E2-related factor (Nrf2) contributes to keep endothelial NO synthase (eNOS) in the coupled state: role of reactive oxygen species (ROS), eNOS, and heme oxygenase (HO-1) levels. |
| Q36811746 | Arrested Hematopoiesis and Vascular Relaxation Defects in Mice with a Mutation in Dhfr |
| Q40374460 | Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure |
| Q92824774 | CR6-interacting factor 1 deficiency reduces endothelial nitric oxide synthase activity by inhibiting biosynthesis of tetrahydrobiopterin |
| Q38991320 | Cell type-specific recycling of tetrahydrobiopterin by dihydrofolate reductase explains differential effects of 7,8-dihydrobiopterin on endothelial nitric oxide synthase uncoupling |
| Q24322688 | Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways |
| Q43220700 | Dexamethasone, tetrahydrobiopterin and uncoupling of endothelial nitric oxide synthase. |
| Q35601395 | Differential effects of eNOS uncoupling on conduit and small arteries in GTP-cyclohydrolase I-deficient hph-1 mice |
| Q43267895 | Dihydrofolate reductase and biopterin recycling in cardiovascular disease |
| Q35064669 | Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency |
| Q36677595 | Down-regulation of dihydrofolate reductase inhibits the growth of endothelial EA.hy926 cell through induction of G1 cell cycle arrest via up-regulating p53 and p21(waf1/cip1) expression |
| Q37066679 | Downregulation of tetrahydrobiopterin inhibits tumor angiogenesis in BALB/c-nu mice with hepatocellular carcinoma |
| Q37711251 | Endothelial dysfunction in diabetes: multiple targets for treatment |
| Q34668310 | Erythropoietin prevents endothelial dysfunction in GTP-cyclohydrolase I-deficient hph1 mice |
| Q46504481 | Evaluation of Mitochondrial Respiratory Chain on the Generation of Reactive Oxygen Species and Cytotoxicity in HaCaT Cells Induced by Nanosized Titanium Dioxide Under UVA Irradiation |
| Q48552624 | Folate: a possible role in erectile dysfunction? |
| Q50450448 | Folic acid supplementation improves microvascular function in older adults through nitric oxide-dependent mechanisms. |
| Q39381101 | Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. |
| Q24293579 | Human endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling |
| Q35190872 | Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. |
| Q37088422 | Increased superoxide and endothelial NO synthase uncoupling in blood vessels of Bmal1-knockout mice |
| Q42145401 | Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells |
| Q36753476 | Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension |
| Q28385682 | Mechanisms of diesel-induced endothelial nitric oxide synthase dysfunction in coronary arterioles |
| Q48687946 | Membrane transport of sepiapterin and dihydrobiopterin by equilibrative nucleoside transporters: a plausible gateway for the salvage pathway of tetrahydrobiopterin biosynthesis. |
| Q89748484 | Methotrexate and its mechanisms of action in inflammatory arthritis |
| Q34727664 | Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes |
| Q37655580 | Molecular mechanisms underlying the activation of eNOS. |
| Q26830146 | Nitric oxide synthases in heart failure |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q90425859 | Oral delivery of xenon for cardiovascular protection |
| Q60952201 | Oxidative Stress in Cardiac Tissue of Patients Undergoing Coronary Artery Bypass Graft Surgery: The Effects of Overweight and Obesity |
| Q38089739 | Pharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions |
| Q26859449 | Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease |
| Q38241490 | Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide |
| Q26822833 | Recoupling the cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recycling |
| Q42919719 | Reply: To PMID 25882860. |
| Q39038629 | Role of folic acid in nitric oxide bioavailability and vascular endothelial function |
| Q35948515 | Role of reactive oxygen and nitrogen species in the vascular responses to inflammation |
| Q37406657 | Role of vitamin C in the function of the vascular endothelium |
| Q34254651 | Roles of tetrahydrobiopterin in promoting tumor angiogenesis |
| Q90460069 | Say NO to ROS: Their Roles in Embryonic Heart Development and Pathogenesis of Congenital Heart Defects in Maternal Diabetes |
| Q37873087 | Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease |
| Q37860512 | Targeting endothelial and myocardial dysfunction with tetrahydrobiopterin |
| Q40536337 | Tetrahydrobiopterin Supplementation Improves Phenylalanine Metabolism in a Murine Model of Severe Malaria. |
| Q33687812 | Tetrahydrobiopterin in cardiovascular health and disease |
| Q47865416 | The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity |
| Q33589215 | Thiol-metabolizing proteins and endothelial redox state: differential modulation of eNOS and biopterin pathways |
| Q41968122 | Uncoupling endothelial nitric oxide synthase is ameliorated by green tea in experimental diabetes by re-establishing tetrahydrobiopterin levels |
Search more.